Timothy C. Kennedy

Timothy C. Kennedy is the Chief Financial Officer of Destination Pet, bringing more than 30 years of financial and operational leadership experience in the healthcare industry. Most recently, Tim served as the Chief Financial Officer, SVP Operations, and Chief Operating Officer of Biocept, a publicly traded liquid biopsy cancer testing company. While at Biocept he oversaw all finance and operating functions raising over $130M in equity over the years. He was also instrumental in launching the company's COVID-19 PCR test in 2020 providing much-needed access to skilled nursing facilities and in-person learning for California Community Colleges, leading to increased revenue and profitability.

Prior to Biocept, Tim served as the Chief Financial Officer of Millennium Health, a privately held leading urine drug testing and pharmacogenetics laboratory company. While at Millennium Health, he was an integral part of securing $1.825 billion of financing and taking Millennium Health through a $2.1 billion restructuring. He has also held executive leadership roles at Plus Diagnostics, Diagnostic Imaging Management, and Laboratory Corporation of America. Tim holds a bachelor's degree in Business - Accounting/Information Technology from Keane University.